Army responds to Kaine, updates discharge regs related to PTSD, TBI
Share
U.S. Senator Tim Kaine applauded the U.S. Army for committing to reforming its policies regarding soldiers diagnosed with PTSD and TBI.
Search Results for U.S. Senate
Share
Sen. Warner requests update on Data Act financial transparency tools
Share
Sen. Mark Warner followed up on his request to more than three-dozen federal agencies to provide Digital Accountability and Transparency Act implementation plans.
Goodlatte, Grassley press for answers about serial rapist deported five times
Share
House Judiciary Chairman Bob Goodlatte wants information about an immigrant deported at least five times and reportedly responsible for nearly a dozen sexual assaults.
Warner, Collins introduce bill to assist small businesses with retirement plans
Share
Sens. Mark Warner and Susan Collins have introduced a bill to reduce filing costs for small business looking to offer retirement plans.
Sen. Warner celebrates Virginia Tech-Google UAS test delivery partnership
Share
Virginia Tech Mid-Atlantic Aviation Partnership and Project Wing will deliver food using unmanned aerial vehicles during research flights.
Kaine denounces Trump as unfit to serve as Commander-in-Chief
Share
Senator Tim Kaine laid out the many reasons why Donald Trump is temperamentally unfit to keep our country safe.
Warner urges Obama to raise financial cybersecurity at G-20 summit
Share
U.S. Sen. Mark R. Warner and five of his colleagues sent a letter to President Obama urging him to prioritize cyberattacks on financial institutions.
Kaine calls out Donald Trump for failure to disclose financial records
Share
Democratic vice presidential nominee Senator Tim Kaine called out Donald Trump for his failure to disclose key information about himself.
Sen. Warner welcomes implementation of federal drone rule
Share
U.S. Sen. Mark R. Warner (D-VA) released a statement regarding the Federal Aviation Administration’s (FAA) small drone rule.
Sen. Warner questions manufacturer on EpiPen price increases
Share
U.S. Sen. Mark R. Warner (D-VA), a member of the Senate Finance Committee, today pressed the only pharmaceutical company that manufactures EpiPens to explain recent increases.
